Evaluation and comparison of efficacy and adverse drug reactions for single or two divided caffeine dosing to treat apnea of prematurity in preterm neonates
Not Applicable
- Conditions
- Apnea of prematurity.Other preterm infants
- Registration Number
- IRCT201510172342N4
- Lead Sponsor
- Vice chancellor for Research, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Neonates with gestational age of 37 weeks
exclusion criteria: asphyxia, hypoglycemia, intracranial hemorrhage, major inherited anomaly
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Extubation failure. Timepoint: during treatment. Method of measurement: Clinical observations.;CPAP failure. Timepoint: during treatment. Method of measurement: clinical observations and levels of blood gases in ABG.
- Secondary Outcome Measures
Name Time Method Adverse reactions. Timepoint: during the treatment. Method of measurement: Questionnaire.